Physiological Role and Molecular Mechanism of Adiponectin Yumi Ando Pomona College Advanced Biochemistry.

Slides:



Advertisements
Similar presentations
ADIPONECTIN Its emerging role in Atherosclerosis, Metabolic Syndrome and Insulin Resistance RT ERASMUS Chemical Pathology, Tygerberg Hospital, NHLS &University.
Advertisements

Biology of Lipid Metabolism Laboratory. People Lab head Matthew Watt Research Assistant Maria Matzaris.
Regulation of food intake. Food intake Regulation –Endocrine Adipose tissue Pancreas Liver Muscle –CNS.
Chapter 22 Energy balance Metabolism Homeostatic control of metabolism
Monash University Student Information Session Professor Bronwyn Kingwell.
Antidiabetic Drugs Until 1994, FDA-approved antidiabetics Insulin and Sulfonylurea Last few years, the list was expanding Insulin (different preparations.
Adiposity in CVD. Role of adipose tissue in atherogenesis Adapted from de Luca C, Olefsky JM. Nat Med. 2006;12:41-2. Lau DCW et al. Am J Physiol Heart.
Diabetes and Aging MCB 135K Laura Epstein 4/14/06.
Homeostatic Control of Metabolism
Source: International Chair on Cardiometabolic Risk Fatty Acid Metabolism in Humans Michael Jensen, MD Division of Endocrinology.
PANCREATIC HORMONES Dr. Amel Eassawi 1. OBJECTIVES The student should be able to:  Know the cell types associated with the endocrine pancreas.  Discuss.
Biological effects of GH Somatotropic –Growth and cell proliferation IGF-I mediated Metabolic –Direct action of GH IGF-I independent Many tissues All nutrients.
Endocrine Physiology PANCREAS Dr. Meg-angela Christi M. Amores.
Absorptive (fed) state
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Endocrine Block | 1 Lecture | Dr. Usman Ghani
By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University By Hussam A.S. Murad.
Factors Released from Adipose Tissue and their Physiological Relevance
Speaker:Chung-Han Wang. introduction Obesity being one of the major issues of public health nowadays, with more than 500 million obese adults worldwide.
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
Sketch of Adiponectin Receptors Hongkui Yu Hongqiang Ye Jie Nie Xiangyu Sun These authors contributed equally to this work.
The Endocrine System Aims: Must be able to outline the main components of the endocrine system and their roles. Should be able to explain how hormones.
Integration of Metabolism
cardio protection: Focus on
Metabolic Integration 1: Metabolic profiles of major organs, signaling and homeostasis, adaptations to starvation Bioc 460 Spring Lecture 40 (Miesfeld)
Glucose Homeostasis By Dr. Sumbul Fatma.
Endocrine Physiology The Endocrine Pancreas. A triangular gland, which has both exocrine and endocrine cells, located behind the stomach Strategic location.
SiRNA unrelated AdipoR1 AdipoR2 None Ad Osm A9 None Ad Osm A9 None Ad Osm A9 Ratio ** Protein (μM) None Ad Osm A siRNA Unrelated.
The Road To Metabolic syndrome
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
Hormones and Homeostasis. Homeostasis  Maintaining a stable internal environment despite unstable external conditions  Examples of systems with homeostasis.
瘦體素 Obesity and Leptin WT ob (db) 2010 Albert Lasker award
Metabolic interrelationship
Transduction of Extracellular Signals Specific receptors in plasma membranes respond to external chemicals (ligands) that cannot cross the membrane: hormones,
 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.
Metabolic effects of insulin & glucagon
Protein Receptors & Signal Transduction
Click to edit Master subtitle style 10/1/2016 Genetic Contribution to Obesity Caitlin Baker Lisa Bakken Gail Feldkamp.
PPAR δ : a dragger in the heart of the metabolic syndrome J.Clin.Invest.116:590~597(2006) R3 Song Se-bin Grant D. Barish, Vihang A.Narkar, and Ronald M.Evans.
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases by Gideon R. Hajer, Timon W. van Haeften, and Frank L.J. Visseren EHJ Volume ():
The role of Leptin& Adiponectin in Rheumatologic disorders
Unit 1 Lesson 6 Activity 3- Insulin and the Human Body
STRUCTURE;TYPES; AND FUNCTION
Integration of Metabolism
The Endocrine Pancreas
Endocrine Block | Dr. Usman Ghani
Glucose Homeostasis By Dr. Sumbul Fatma.
Obesity Dr. Sumbul Fatma.
Intermyocellular fat depot
6.6 – Hormones, homeostasis and reproduction
Volume 47, Issue 1, Pages (July 2007)
Vascular biology of metabolic syndrome
Insulin Beef Drugbank ID : DB09456 Molecular Weight (Daltons) :5733.5
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
White adipose tissue (HFD)
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Figure 1 Simplified representation of the physiological
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Hua V. Lin, Domenico Accili  Cell Metabolism 
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
Selective Insulin and Leptin Resistance in Metabolic Disorders
Nat. Rev. Endocrinol. doi: /nrendo
Konstantinos G. Michalakis, M.D., James H. Segars, M.D. 
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism  Barbara B. Kahn, Thierry Alquier, David Carling,
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
Figure 2 Initiators of obesity-associated inflammation in adipocytes
Glucagon – A hormone from pancreas Lecture NO: 2nd MBBS
Macrophages, Immunity, and Metabolic Disease
The Endocrine Pancreas
Presentation transcript:

Physiological Role and Molecular Mechanism of Adiponectin Yumi Ando Pomona College Advanced Biochemistry

What is Adiponectin??  A signaling molecule that is secreted from white and brown adipose tissue.  Composed of 247 amino acids.  Accounts for 0.05 % of total serum protein.  Concentration: 2~20 μg/mL in the blood

Aside: Adipose Tissue  Adipose tissue stores & releases energy in the form of TAG and free fatty acids, respectively.  HOWEVER, it is also gaining recognition as an endocrine organ that secretes proteins w/ pro- inflammatory effects, as well as metabolic effects.  These proteins are called “adipocytokines” or “adipokines”  Examples: adiponectin, leptin, resistin.

Structure of adiponectin  3 domains: Collagen-like domain, globular domain, and a signal sequence. Taken from Kadowaki and Yamauchi, 2004

 Form homomultimers  3 main oligomeric forms: LMW, MMW, and HMW  Oligomerization of adiponectin depends on disulphide bonds formed by Cys39 Taken from Kadowaki and Yamauchi, 2005

Two forms, two different functions?  Adiponectin can exist as a full-length protein or as a globular form by undergoing proteolytic cleavage, which leaves only the globular head domain intact.  The globular form of adiponectin appears to stimulate β oxidation in muscle, while the full-length form appears to decrease glucose output by the liver

Genetic Factors  The gene for adiponectin is located on chromosome 3q27.  This region of the chromosome has also been linked to type 2 diabetes.  A SNP located 276 base pairs downstream of the start site of the adiponectin gene was associated with increased insulin resistance and risk of developing type 2 diabetes.

Why is it important to study adiponectin?  Evidence strongly suggests that adiponectin plays a role in the pathophysiology of type 2 diabetes and other metabolic syndrome diseases!!

Correlation between adiponectin and insulin resistance  Obesity and type 2 diabetes are associated with decreased adiponectin levels  Reduced plasma adiponectin is also seen in people with conditions such as cardiovascular disease and hypertension, diseases that are often associated with insulin resistance.

 In a study conducted by Hotta et al., (2001), plasma adiponectin levels dropped in parallel to the observation of decreased insulin sensitivity in rhesus monkeys.  Monkeys w/ decreased insulin sensitivity developed type 2 diabetes.

Molecular Mechanism of Adiponectin  A study conducted by Yamauchi et al. (2001) showed that adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP- activated protein kinase.

Adiponectin Receptors  There are two known ones: AdipoR1 and AdipoR2.  They are integral membrane proteins that have seven transmembrane domains where the N terminus is located within the cell, and the C terminus is external.  AdipoR1 is a receptor that mainly binds globular adiponectin, while AdipoR2 binds to full-length adiponectin  AdipoR1 is abundant in skeletal muscle. On the other hand, AdipoR2 is most expressed in the liver.

Possible therapeutic strategies…  3 methods have been studied.  Upregulation of adiponectin  Upregulation of adiponectin receptors  Development of adiponectin receptor agonists

Osmotin  potential agonist for adiponectin!!  It is a plant protein that is implicated in the plant defense system. Causes apoptosis in yeast.  adiponectin and osmotin were able to induce phosphorylation of AMP kinase in C2C12 myocytes.

5 things to remember…  adiponectin is a potent insulin sensitizing molecule.  The two forms (globular and full-length) bind to different receptors and have different effects.  Decreased levels of adiponectin induced by genetic mutations, obesity, and high fat diets lead to insulin resistance and pathological conditions such as type 2 diabetes.  Adiponectin activates signaling cascades that eventually increase glucose uptake by muslce, increase fatty acid oxidation by muscle and liver, and decrease gluconeogenesis in the liver.  In the future, Osmotin could be used as a novel therapeutic method for hypoadiponectinemia.

References  Cnop M. et al. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 46: 459–469.  Fasshauer M., Paschke R., and Stumvoll, M. (2004) Adiponectin, obesity, and cardiovascular disease. Biochimie. 86:  Lihn A.S., Pedersen S.B., and Richelsen B. (2004) Adiponectin: action, regulation, and association to insulin sensitivity. Obesity Reviews. 6:  Fruebis J. et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 98:  Hara K., et al. (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 51:536–540.  Hotta K., et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 50:1126–1133  Kadowaki T., and Yamauchi T. (2005) Adiponectin and Adiponectin Receptors. Endocrine Reviews. 26(3):  Kadowaki T. et al.(2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation. 116(7):  Kubota N., et al. (2006) Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and adiponectin- independent pathways. J. Biol. Chem. 281(13):  Narasimhan M.L. et al. (2005) Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptors. Molecular Cell. 17(2):  Qi Y. et al. (2004) Adiponectin acts in the brain to decrease body weight. Nature Medicine. 10:  Shapiro L. and Scherer, P.E. (1998) The crystal structure of complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology. 8:  Yamauchi T., et al. (2001) The fat-derived horomone adiponectin reverses insulin resistance associated ith both lipoatrophy and obesity. Nature. 7(8):  Yamauchi T., et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 8(11):  Yamauchi et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 423: